Fundación Valle del Lili
Cali, Colombia
NCT Number: NCT03135158
The present study aims to determine the relationship between postpartum changes in the shock index and the severity of blood loss and other PPH results. Blood loss, heart rate and blood pressure will be systematically measured in the postpartum period in all participating women to explore new clinical indicators to identify those requiring clinical intervention for excessive bleeding.
Looking for future studies?
Notify MeFemale
Observational
Cali, Colombia
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Women who have vaginal births are observed for a minimum of 1 hour postpartum
Time frame: Within 1 hour postpartum
Correlate shock index, heart rate, and blood pressure measurements with blood loss levels at 15, 30, 45 & 60 minutes
Time frame: Up to two hours postpartum
Proportions with ≥ 500 ml and ≥ 1000 ml blood loss at 30 and 60 minutes postpartum, at PPH diagnosis (if applicable), and when active bleeding stops
Time frame: Up to two hours postpartum
Blood loss at 30 and 60 minutes postpartum, at PPH diagnosis (if applicable), and when active bleeding stops
Time frame: Up to two hours postpartum
Time frame: Pre-delivery and at least 24 hours postpartum
Among women receiving treatment to control postpartum hemorrhage
Time frame: Through study completion, an average of 24-48 hours postpartum
Among women receiving treatment to control postpartum hemorrhage
Gynuity Health Projects
Other
The Association Between Shock Index and Severity of Postpartum Blood Loss: An Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06192836
Cesarean Section Complications, Dystocia
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06635564
Bleeding Disorder, Brain Diseases
Vienna, Austria
View Trial DetailsNCT03120208
Depression, Postpartum, Depressive Disorder
Clermont-Ferrand, France
View Trial DetailsNCT07689136
Cardiovascular Diseases, Deep Vein Thrombosis
Tunis, Tunisia
View Trial Details